Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology
- 1 November 2017
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 86, 178-185
Abstract
No abstract availableKeywords
Funding Information
- EHR
- EHR
This publication has 32 references indexed in Scilit:
- The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysisTumor Biology, 2017
- Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973–2013)HPB Surgery, 2017
- Uses of cancer registries for public health and clinical research in Europe: Results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010–2012European Journal of Cancer, 2015
- EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluationEuropean Journal of Cancer, 2015
- Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based studyThe Lancet Oncology, 2014
- The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?New England Journal of Medicine, 2013
- Are ongoing trials on hematologic malignancies still excluding older subjects?Haematologica, 2013
- Bridging The Inferential Gap: The Electronic Health Record And Clinical EvidenceHealth Affairs, 2007
- Information Technology And The Inferential GapHealth Affairs, 2007
- Evidence based medicine: what it is and what it isn'tBMJ, 1996